Specifically, abnormally low expression of the E3 ligase SMURF2 led to a decrease in the SMURF2-RACK1 complex, resulting in decreased ubiquitination of RACK1 and increased stability, which promoted tumor progression. This evidence concerns the gene SMURF2 and neoplasm.